Genomic and transcriptomic analysis in a subset of patients (n = 45) showed that PTEN somatic mutations were significantly associated with immunosuppressive expression signatures in non-responder tumors, suggesting that PTEN may play a role in the establishment of a specific tumor-immune microenvironment. This evidence concerns the gene PTEN and neoplasm.